Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

AMC Entertainment

Carnival

Alibaba

New Jersey's embattled pension initiated a position in AMC Entertainment, increased investments in marijuana stock Tilray and cruise giant Carnival, and slashed its stake in Alibaba.

A Giant Fund Scooped Up AMC Stock, Bought More Tilray and Carnival

Behold that rarest of all animals on the exchange -- a profitable cannabis company!

Why Tilray Is Trouncing the Market This Week

Aurora Cannabis

Canopy Growth

Clever Leaves Holdings Inc

Grove

GrowGeneration Corp

High Tide

IM Cannabis Corp

Coffee Holding

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks and look ahead to how the cannabis industry continues to shape up in 2021.

10 Cannabis Stocks That Ran Extra Hot This Week

CALGARY, AB, July 30, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV: HITI) (Nasdaq: HITI) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, today announced that as per the recently disclosed listing of holdings available on its website, the Company's shares have now been included in Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ). "We are very pleased to have our shares included in the Horizons Marijuana Life Sciences Index ETF," said Raj Grover, President and Chief Executive Officer of High Tide.

High Tide Announces Addition to the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ ) and Results of Annual General Meeting

Tilray posted an unexpected profit in Q4. However, there's more to the story.

Is Tilray Stock a Buy After Its Surprising Q4 Profit?

HEXO Corp

OrganiGram Holdings Inc.

SNDL Inc.

The Senate's marijuana legalization bill "will not pass."

Why Hexo, Tilray, OrganiGram, and Sundial Stocks Are Wilting

Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) confirmed Thursday it has summoned and postponed its long-anticipated special meeting of shareholders, at which stockholders were meant to vote on two important proposals – 1) Share dilution and 2) Several governance changes with the purpose of increasing stockholders rights. The special meeting was adjourned until August 19.

Tilray Postpones Special Meeting To Solicit Proxies, Says Majority Of Shareholders Support Dilution And Other Proposals

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today convened and then adjourned the Special Meeting of Stockholders intended to approve two shareholder proposals: (1) a proposal to increase the authorized number of shares of common stock (“Authorized Shares Proposal”); and (2) a number of governance enhancements to increase stockholder rights (the “Governanc

Tilray Announces Adjournment of Special Meeting of Stockholders to August 19, 2021

Tilray Inc (NASDAQ:TLRY) shot up over 25% on Wednesday following the release of the cannabis giant's record fourth-quarter 2021 results and a bullish conference call where CEO Irwin Simon projected 2024 revenues of $4 billion. The stock made most of its gains in the first half-hour of the trading session, gapping up 11% and running another 11% higher by 10 a.m.

Short Squeeze? Tilray Stock Soars On Standout Earnings

Shares of Tilray (TLRY) closed sharply higher in Wednesday's trading session, gaining 25.8% after reporting mixed fourth-quarter earnings results.

Why Cannabis Giant Tilray (TLRY) Skyrocketed Today

Ford Motor Company

Microsoft

Pfizer

Shopify

Ford, Shopify, Microsoft, Pfizer and Tilray were our top stock trades for Thursday. That said, let's get a look at the charts now.

5 Top Stock Trades for Thursday: F, SHOP, MSFT, PFE, TLRY

Cannabis company Tilray Inc. (NASDAQ:TLRY) shares soared more than 27% on Wednesday after announcing its most recent quarterly results. The company posted a significant cannabis revenue increase in its fiscal Q4 report but missed analyst expectations on the total revenue.

Tilray stock price predictions for August 2021 after Q4 revenue miss

Tilray Inc (NASDAQ: TLRY) said on Wednesday it concluded the fiscal fourth quarter with a surprise profit. Shares of the company are up almost 30% today.

Here's why Tilray shares are up nearly 30% on Wednesday

Canadian cannabis giant Tilray, Inc. (NASDAQ:TLRY) (TSX:TLRY) reported its latest financial results on Wednesday, touting a spike in both fourth-quarter and full fiscal 2021 revenue. CEO Irwin D.

LIVE 2:30 PM ET: Tilray CEO Discusses Earnings, Answers Audience Questions

Shares of Canadian cannabis company Tilray Inc. jumped 26% Wednesday, after the company posted a surprise profit for its fiscal fourth quarter, in its first earnings report since it closed its merger with Aphria Inc. in May.

Cannabis Watch: Tilray shares rocket 26% after it swings to a surprise profit and target of $4 billion in revenue by 2024

Tilray, Inc. (TLRY) CEO Irwin Simon on Q4 2021 Results - Earnings Call Transcript

Tilray is down nearly 95% from it's all-time high but many retail traders appear optimistic the cannabis stock will rally "to the moon."

Retail traders are cheering on Tilray's 27% pop after the cannabis company's first earnings report since merging with Aphria

The stock price of Tilray Inc (NASDAQ: TLRY) increased by over 27% during intraday trading. This is why it happened.

TLRY Stock Increases Over 27% Intraday: Why It Happened

Cannabis stocks are on the rise today. As legalization looms, the industry has been moving invariably.

Cannabis Stocks: Why TLRY, CGC, ACB, SNDL Stocks Are Getting High Today

Chefs' Warehouse

Great businesses don't all involve silicon and circuit boards.

Forget Big Tech! These Were the Real Nasdaq Winners Wednesday.

Now that cannabis firms Tilray and Aphria completed heir merger, the combined company says it's on track to deliver $80 million in cost savings in the next 16 months.

Tilray Stock Is Up After Surprise Quarterly Profit

The cannabis company reported a surprise profit in the latest quarter.

Here's Why Tilray Stock Soared Wednesday Morning

Canadian cannabis giant Tilray, Inc. (NASDAQ:TLRY) (TSX:TLRY) posted its latest financial earnings report Wednesday, touting a spike in both fourth quarter and full fiscal 2021 revenue and a proclamation from CEO Irwin D. Simon that Tilray is "leading the global cannabis industry with low cost of production, leading brands, a well-developed distribution network, and unique partnerships.

Tilray Shares Up On Reporting First Results Since Merger With Rival Aphria, Reveals $33.6M Profit In Q4

Tilray, Inc. (TLRY) delivered earnings and revenue surprises of -37.50% and -0.49%, respectively, for the quarter ended May 2021. Do the numbers hold clues to what lies ahead for the stock?

Tilray, Inc. (TLRY) Reports Q4 Loss, Misses Revenue Estimates

Shares of Canadian cannabis company Tilray Inc. jumped 5.9% in premarket trade Wednesday, after it swung to a profit in its fiscal fourth quarter. Tilray said it had net income of $33.5 million in the quarter to May 31, or 18 cents a share, after a loss of $84.3 million, or 39 cents a share, in the year-earlier period.

News for Tilray Brands Stock (TLRY)